All radiation treatments except brachytherapy are limited to this prostate dose to avoid side effects. This lower dose has a 10 year PSA relapse-free survival of 85% (depends on the prostate cancer risk). The higher prostate dose can only be achieved by the limited area of radiation emitted from individual seeds.
http://www.mciverclinic.com/prostate/prostate_cancer/radiation_therapy/localized_treatment/
Until 1992 prostate cancer was most often found as a result of a digital rectal examination (DRE), in reviewing tissue samples from a transurethral resection of the prostate (TURP) or when symptoms manifested an advanced stage of the disease.
http://www.prostate-online.com/risingpsa.htm
A The 10 year PSA relapse-free survival was 92% for men with high risk prostate cancer treated with the combination of Palladium seed implant followed by IMRT/IGRT. Some, but not all of these patients, received adjuvant hormonal deprivation therapy ranging from 4 to 18 months.
http://www.mciverclinic.com/prostate/prostate_cancer/radiation_therapy/localized_treatment/
The main benefit of a radical prostatectomy is that the cancer is removed with the prostate. This is true as long as cancer hasn't spread outside the prostate. Surgery also helps the health care provider find out whether the cancer has moved beyond the prostate. If your prostate cancer is confined to the prostate, the cahcne of cure with surgery alone at 10 years (undetectable PSA) is more than 90 percent. If your cancer has gone beyond the prostate gland, surgery is also a good choice.
http://www.urologyhealth.org/urologic-conditions/prostate-cancer/treatment/surgery
After external beam radiation for prostate cancer, this study finds, a longer period of PSA fall and lower PSA nadir predicts higher chance of disease-free survival. Higher dose of radiation (at or above 70 Gy) significantly improves this chance. March 16, 2006.
http://www.psa-rising.com/med/ebr/nadir_survivalpostrad06.htm
Now the prostate specific antigen (PSA) blood test has become the primary marker for measuring the potential and/or presence of prostate cancer (Pca). We are advised to begin regular PSA testing somewhere between the ages of 40 to 50, dependent upon our race, ethnicity, family medical history, symptomatic conditions, etc.
http://www.prostate-online.com/risingpsa.htm
Answer: PSA and Digital rectal exam are the mainstay of evaluation. Typically, we follow patients every 3 – 4 months for 2 years, then every 6 months until year 5. After year 5, it is annually. Bone scan, CT, MRI and the new F-18/PET/CT-Bone scan are ordered if there is a PSA rise.
http://www.mciverclinic.com/prostate/prostate_cancer/radiation_therapy/localized_treatment/
Lymph node involvement is associated with recurrence of the prostate cancer in more than 85% of patients. There is also a greater risk of recurrence if the volume of cancer in the prostate is large (i.e., if most of the prostate gland has been replaced by cancer) or if the preoperative PSA level is high.
http://www.drcatalona.com/quest/quest_spring03_3.htm
March 16, 2006. Prostate cancer patients who have a lower prostate specific antigen (PSA) nadir after external beam radiation therapy to treat their prostate cancer are less likely to have the cancer return or spread to other parts of their body than patients with a higher PSA nadir.
http://www.psa-rising.com/med/ebr/nadir_survivalpostrad06.htm
AT: PSA is a protein produced specifically by prostate cells that is a component of semen. As such it is an organ specific marker. It is contained within the prostate and is usually detected in small amounts in the blood stream under normal conditions.
http://www.prostate-online.com/risingpsa.htm
how long for psa to fall after prostate trauma
it takes every 3 to 4 months for 2 years, then every 6 months until year 5 for psa to fall after prostate trauma. A prostate-specific antigen fall every 3 to 4 months for 2 years, then every 6 months until 5 years after prostate trauma. A prostate-specific antigen is fall every 3 to 4 months for 2 years, then every 6 months until 5 years after prostate trauma.